Case report: ALK-positive histiocytosis presented as bilateral synchronous breast masses with long-term remission on crizotinib
ALK-positive histiocytosis (APH) is a rare type of histiocytic neoplasm with characteristic ALK (Anaplastic Lymphoma Kinase) gene translocation and fusion, with only 27 reported cases in the literature. In this study, we report the first case of synchronous bilateral breast involvement of ALK-positi...
Main Authors: | Yuhang Zhou, Marisabel Hurtado-Castillo, Om Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2023.1288849/full |
Similar Items
-
Clinical Efficacy of Crizotinib in Advanced ALK Positive
Non-small Cell Lung Cancer
by: Jing ZHAO, et al.
Published: (2015-10-01) -
Efficacy and Safety of Crizotinib in Advanced or Recurrent
ALK-positive Non-small Cell Lung Cancer
by: Xiaoyan LI, et al.
Published: (2019-08-01) -
Successful Retreatment with Crizotinib After Crizotinib-Induced Liver Failure in ALK-Positive Advanced Lung Adenocarcinoma: A Case Report
by: Zhang X, et al.
Published: (2023-01-01) -
Clinical outcome, long‐term survival and tolerability of sequential therapy of first‐line crizotinib followed by alectinib in advanced ALK+NSCLC: A multicenter retrospective analysis in China
by: Zihua Zou, et al.
Published: (2022-01-01) -
Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review
by: Qiang He, et al.
Published: (2022-05-01)